McDade Mark's Form 4 filing
Jasper Therapeutics, Inc. (JSPR) · filed Apr 11, 2023
- Accession no.
- 0001209191-23-024058
- Filed
- Apr 11, 2023, 7:55 PM ET
- Trade date
- Jan 27, 2023
- Filing delay
- 74 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $4.00M. It was filed 74 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McDade MarkCIK 0001242126 | 10% Owner |
| Rieschel Gary ECIK 0001248153 | 10% Owner |
| Qiming U.S. Healthcare Fund II, L.P.CIK 0001765710 | 10% Owner |
| Qiming U.S. Healthcare GP II, LLCCIK 0001868862 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | Voting Common Stock | PPurchaseAcquired | +2,666,666 | $1.50 | +$3,999,999 | 8,519,648 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.